S A Messer - JoVE Visualize

Showing results (31-40 of 108) with videos related to

Pageof 11

Sort By:

Antimicrobial Agents and Chemotherapy|June 13, 1998

Evaluation of endpoints for antifungal susceptibility determinations with LY303366M E Klepser, E J Ernst, M E Ernst, et al.

Diagnostic Microbiology and Infectious Disease|May 23, 1998

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.

Journal of Clinical Microbiology|March 7, 2002

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000M A Pfaller, D J Diekema, R N Jones, et al.

Diagnostic Microbiology and Infectious Disease|March 26, 1999

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methodsE J Ernst, M E Klepser, M E Ernst, et al.

Journal of Clinical Microbiology|January 9, 2003

Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformansM J Maxwell, S A Messer, R J Hollis, et al.

The Journal of Antimicrobial Chemotherapy|January 30, 2002

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida speciesR E Lewis, D J Diekema, S A Messer, et al.

Antimicrobial Agents and Chemotherapy|May 23, 2002

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida sppM A Pfaller, S A Messer, R J Hollis, et al.

Diagnostic Microbiology and Infectious Disease|December 24, 1997

An outbreak of Candida parapsilosis prosthetic valve endocarditisD J Diekema, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|May 1, 1996

Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazoleH Sanati, S A Messer, M Pfaller, et al.

Journal of Clinical Microbiology|November 6, 2004

Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida speciesM A Pfaller, L Boyken, S A Messer, et al.

Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:

Pageof 11

Antimicrobial Agents and Chemotherapy|June 13, 1998

Evaluation of endpoints for antifungal susceptibility determinations with LY303366M E Klepser, E J Ernst, M E Ernst, et al.

Diagnostic Microbiology and Infectious Disease|May 23, 1998

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.

Journal of Clinical Microbiology|March 7, 2002

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000M A Pfaller, D J Diekema, R N Jones, et al.

Diagnostic Microbiology and Infectious Disease|March 26, 1999

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methodsE J Ernst, M E Klepser, M E Ernst, et al.

Journal of Clinical Microbiology|January 9, 2003

Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformansM J Maxwell, S A Messer, R J Hollis, et al.

The Journal of Antimicrobial Chemotherapy|January 30, 2002

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida speciesR E Lewis, D J Diekema, S A Messer, et al.

Antimicrobial Agents and Chemotherapy|May 23, 2002

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida sppM A Pfaller, S A Messer, R J Hollis, et al.

Diagnostic Microbiology and Infectious Disease|December 24, 1997

An outbreak of Candida parapsilosis prosthetic valve endocarditisD J Diekema, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|May 1, 1996

Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazoleH Sanati, S A Messer, M Pfaller, et al.

Journal of Clinical Microbiology|November 6, 2004

Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida speciesM A Pfaller, L Boyken, S A Messer, et al.

Pageof 11